Biocon board to mull Thu buying equity shares in arm Biocon Biologics
This story was originally published at 19:56 IST on 4 May 2026
Register to read our real-time news.Informist, Monday, May 4, 2026
--Biocon board to mull buying equity shares in arm Biocon Biologics on Thu
MUMBAI – Biocon Ltd.'s board will consider on Thursday buying equity shares of its subsidiary Biocon Biologics Ltd. As part of the purchase, Biocon will allot its shares on a preferential basis through private placement.
Biocon holds just over 90% stake in Biocon Biologics, according to the company's annual report. For the December quarter, Biocon reported a consolidated net profit of INR 1.44 billion on revenues of INR 41.73 billion. Monday, shares of the company closed 0.3% higher at INR 360.60 per share on the National Stock Exchange. End
Reported by Anshul Choudhary
Edited by Saji George Titus
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe
Share this Story:
